Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,754 | 177 | 96.0% |
| Education | $157.74 | 5 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,087 | 63 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,060 | 49 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $629.16 | 22 | $0 (2024) |
| Alkermes, Inc. | $287.52 | 15 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $224.57 | 4 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $184.89 | 11 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $137.85 | 6 | $0 (2024) |
| ITI, Inc. | $113.74 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $51.73 | 3 | $0 (2021) |
| Lundbeck LLC | $40.34 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.78 | 9 | Otsuka America Pharmaceutical, Inc. ($125.00) |
| 2023 | $819.29 | 42 | AbbVie Inc. ($475.62) |
| 2022 | $649.84 | 40 | ABBVIE INC. ($411.79) |
| 2021 | $292.70 | 16 | AbbVie Inc. ($139.41) |
| 2020 | $156.27 | 3 | Otsuka America Pharmaceutical, Inc. ($134.18) |
| 2019 | $583.50 | 15 | Sunovion Pharmaceuticals Inc. ($220.50) |
| 2018 | $667.16 | 34 | Sunovion Pharmaceuticals Inc. ($465.15) |
| 2017 | $446.37 | 23 | Sunovion Pharmaceuticals Inc. ($373.99) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $33.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.87 | General |
| Category: PSYCHIATRY | ||||||
| 01/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Education | In-kind items and services | $5.15 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: PSYCHIATRY | ||||||
| 08/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Lundbeck LLC | ABILIFY ASIMTUFII (Drug) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: PSYCHIATRY | ||||||
| 07/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 422 | 1,679 | $207,131 | $133,788 |
| 2022 | 5 | 626 | 1,948 | $251,388 | $162,741 |
| 2021 | 4 | 685 | 1,768 | $297,577 | $158,651 |
| 2020 | 8 | 460 | 1,058 | $160,800 | $84,035 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 866 | $109,599 | $71,006 | 64.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 120 | 566 | $53,343 | $34,626 | 64.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 49 | 56 | $14,800 | $9,847 | 66.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 50 | 63 | $17,036 | $9,590 | 56.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 74 | 128 | $12,354 | $8,720 | 70.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 647 | $81,382 | $54,736 | 67.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 188 | 536 | $51,102 | $34,610 | 67.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 113 | 491 | $49,108 | $31,481 | 64.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 133 | 196 | $53,143 | $30,672 | 57.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 48 | 48 | $12,899 | $8,690 | 67.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 20 | 30 | $3,754 | $2,552 | 68.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 290 | 396 | $142,023 | $61,911 | 43.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 197 | 736 | $64,428 | $48,026 | 74.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 387 | $36,699 | $27,227 | 74.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 64 | 196 | $35,241 | $12,333 | 35.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 51 | 53 | $19,186 | $9,155 | 47.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 147 | 173 | $59,386 | $21,966 | 37.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 121 | 339 | $29,992 | $21,961 | 73.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 309 | $29,306 | $20,872 | 71.2% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 21 | 43 | $7,920 | $5,128 | 64.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 27 | 53 | $7,794 | $3,404 | 43.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 49 | $10,192 | $3,378 | 33.1% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2020 | 22 | 24 | $4,345 | $2,759 | 63.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 19 | 19 | $6,230 | $2,724 | 43.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 19 | 49 | $5,635 | $1,842 | 32.7% |
About Sandip Sheth
Sandip Sheth is a Psychiatry healthcare provider based in Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972548915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandip Sheth has received a total of $3,912 in payments from pharmaceutical and medical device companies, with $296.78 received in 2024. These payments were reported across 182 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,754).
As a Medicare-enrolled provider, Sheth has provided services to 2,193 Medicare beneficiaries, totaling 6,453 services with total Medicare billing of $539,215. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Richmond Hill, NY
- Active Since 06/16/2006
- Last Updated 06/21/2019
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1972548915
Products in Payments
- VRAYLAR (Drug) $1,119
- LATUDA (Drug) $1,060
- ABILIFY MAINTENA (Drug) $485.22
- INGREZZA (Drug) $224.57
- AUSTEDO (Drug) $184.89
- REXULTI (Drug) $163.81
- Aristada 441 mg (Drug) $140.07
- TRINTELLIX (Drug) $137.85
- CAPLYTA (Drug) $113.74
- LYBALVI (Drug) $93.28
- ARISTADA (Drug) $54.17
- INVEGA SUSTENNA (Drug) $32.23
- COBENFY (Drug) $27.27
- ABILIFY ASIMTUFII (Drug) $20.47
- INVEGA TRINZA (Drug) $19.50
- MYDAYIS (Drug) $19.41
- NUEDEXTA (Drug) $17.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Richmond Hill
Dr. Meri Nisimova, Md, MD
Psychiatry — Payments: $3,770
Dr. Madhu Malhotra
Psychiatry — Payments: $2,041
Adam Harris, Md, MD
Psychiatry — Payments: $323.77
Dr. Grisco Blanco, M.d, M.D
Psychiatry — Payments: $17.32
Dr. Lilian Aldana-Bernier
Psychiatry
Dr. Indira Patel
Psychiatry